Gaetana Capobianco

RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma

Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo et al. · British Journal of Haematology · 2011 · 76 citations

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

Gaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone et al. · Cancer Chemotherapy and Pharmacology · 2009 · 75 citations

B-cell Lymphoma, Lymphoid Neoplasia, Hematological Malignancy +8

Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy

Gaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone et al. · British Journal of Haematology · 2011 · 58 citations · Full text

Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma

Luigi Aloj, Laura D’Ambrosio, Michela Aurilio et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 33 citations

Lymphoid Neoplasia, Refractory Hodgkin, Autoimmune Disease +13

Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.

Gaetano Corazzelli, Gaetana Capobianco, Filippo Russo et al. · PubMed · 2005 · 31 citations

Lymphoid Neoplasia, Single Agent, Medicine +13